» Articles » PMID: 25061536

Clinical Practice Guidelines for Gastric Cancer in Korea: an Evidence-based Approach

Abstract

Although gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to those in western countries. However, there are currently no Korean multidisciplinary guidelines for gastric cancer. Experts from related societies developed guidelines de novo to meet Korean circumstances and requirements, including 23 recommendation statements for diagnosis (n=9) and treatment (n=14) based on relevant key questions. The quality of the evidence was rated according to the GRADE evidence evaluation framework: the evidence levels were based on a systematic review of the literature, and the recommendation grades were classified as either strong or weak. The applicability of the guidelines was considered to meet patients' view and preferences in the context of Korea. The topics of the guidelines cover diagnostic modalities (endoscopy, endoscopic ultrasound, and radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, and radiotherapy), and pathologic evaluation. An external review of the guidelines was conducted during the finalization phase.

Citing Articles

Advancing Systemic Therapy in Gastric Cancer: Key Updates From the Korean Practice Guidelines for Gastric Cancer 2024.

Ryu M, Ryu K J Gastric Cancer. 2025; 25(1):1-4.

PMID: 39822169 PMC: 11739644. DOI: 10.5230/jgc.2025.25.e6.


Clinicopathological Characteristics and Lymph Node Metastasis Rates in Early Gastric Lymphoepithelioma-Like Carcinoma: Implications for Endoscopic Resection.

Kim T, An J, Choi M, Lee J, Sohn T, Bae J Gut Liver. 2024; 18(5):807-813.

PMID: 39054912 PMC: 11391134. DOI: 10.5009/gnl240006.


Stomach Cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population.

Wu B, Dong E, Chen Q, Luong T, Lustigova E, Jeon C PLoS One. 2024; 19(5):e0303153.

PMID: 38771811 PMC: 11108155. DOI: 10.1371/journal.pone.0303153.


A Modified eCura System to Stratify the Risk of Lymph Node Metastasis in Undifferentiated-Type Early Gastric Cancer After Endoscopic Resection.

Yang H, Lee H, Kim T, Jung D, Choi K, Ahn J J Gastric Cancer. 2024; 24(2):172-184.

PMID: 38575510 PMC: 10995829. DOI: 10.5230/jgc.2024.24.e13.


Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center.

Raptis D, Maak M, Krautz C, Merkel S, Brunner M, Agaimy A Arch Med Sci. 2024; 20(1):124-132.

PMID: 38414452 PMC: 10895969. DOI: 10.5114/aoms/141165.


References
1.
Kim J, Hur Y, Yang H . Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol. 1995; 2(4):308-13. DOI: 10.1007/BF02307062. View

2.
Makino T, Fujiwara Y, Takiguchi S, Tsuboyama T, Kim T, Nushijima Y . Preoperative T staging of gastric cancer by multi-detector row computed tomography. Surgery. 2011; 149(5):672-9. DOI: 10.1016/j.surg.2010.12.003. View

3.
Bang Y, Van Cutsem E, Feyereislova A, Chung H, Shen L, Sawaki A . Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010; 376(9742):687-97. DOI: 10.1016/S0140-6736(10)61121-X. View

4.
Hofmann M, Stoss O, Shi D, Buttner R, van de Vijver M, Kim W . Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008; 52(7):797-805. DOI: 10.1111/j.1365-2559.2008.03028.x. View

5.
Yoo C, Sohn B, Han W, Pae W . Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study. World J Surg. 2005; 29(12):1592-9. DOI: 10.1007/s00268-005-7793-1. View